Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.

@article{Farley2010AntidepressantlikeEO,
  title={Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.},
  author={S{\'e}verine Farley and Kalliopi Apazoglou and Jeffrey M. Witkin and Bruno Giros and Eleni T. Tzavara},
  journal={The international journal of neuropsychopharmacology},
  year={2010},
  volume={13 9},
  pages={
          1207-18
        }
}
Enhancement of AMPA receptor (AMPAR) function has emerged as a novel strategy for treatment of depression. Nevertheless, studies on AMPAR function in chronic animal models used to predict antidepressant efficacy are surprisingly lacking. We investigated the role of AMPARs in antidepressant action in an unpredictable chronic mild stress (UCMS) model in BALB/c mice. After 3 wk of UCMS, BALB/c mice developed a number of depressive-like behaviours that were successfully prevented by fluoxetine (20… 

Figures from this paper

S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms
TLDR
The antidepressant/anxiolytic-like effects of S 47445 are investigated in a mouse model of anxiety/depression based on chronic corticosterone administration and in the Chronic Mild Stress model in rats, showing robust antidepressant-anxionistic-like properties after chronic administration through neurogenesis dependent/independent mechanisms and neuroplastic activities.
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice.
TLDR
It is found that postsynaptic AMPAR activation followed by activation of L-VDCC and subsequent VGF/BDNF/TrkB/AKT signaling are required for the rapid antidepressant effects of PF-4778574, and a promising therapeutic profile is found for this novel AMPAR positive allosteric agonist.
Functional status of somatodendritic 5-HT1A autoreceptor after chronic treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration
TLDR
Cellular explanations on the reasons why SSRIs produce antidepressant effects in pathological conditions but not in naïve animals or healthy volunteers are provided.
Functional Status of Somatodendritic Serotonin 1A Autoreceptor after Long-Term Treatment with Fluoxetine in a Mouse Model of Anxiety/Depression Based on Repeated Corticosterone Administration
TLDR
Cellular explanations for the antidepressant effects produced by SSRIs in subjects with pathological conditions but not in naive animals or healthy volunteers are provided.
Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats
TLDR
The fact that all three anti-dementia drugs reversed CMS-induced cognitive impairment and that cholinesterase inhibitors, but not memantine, have antidepressant-like effects in this model suggest that different mechanisms may underlie CMS- induced anhedonia and cognitive impairment.
Positive allosteric modulation of &agr;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action
TLDR
It is suggested that AMPAR neurotransmission plays opposite roles in anxiety and depression as AMPAR potentiation facilitated the antidepressant-like effects of citalopram while attenuating its anxiolytic-like effect.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors
TLDR
Together with other evidence for a role of AMPA receptors in the efficacy of antidepressants, the current data suggest that the addition of an ARP may augment the activity and perhaps the onset of the therapeutic effects of biogenic amine and second messenger-based antidepressants.
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal
Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation
TLDR
5-HT6 receptor stimulation may be a mechanism initiating some of the biochemical and behavioral outcomes of 5-HT reuptake inhibitors, such as fluoxetine, which indicates that selective 5- HT6 receptor agonists may represent a novel antidepressant drug class.
AMPA receptors in the therapeutic management of depression.
TLDR
Data from mutant mice suggest that AMPA receptors may regulate the expression of brain-derived neurotrophic factor, a neurotrophin which has been implicated in the actions of antidepressant therapies, and that compounds which target AMPA receptor receptors may prove useful in the clinical management of depression.
Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function?
TLDR
There could be an increase in calcium permeability of AMPA receptors in limbic/striatal brain regions after maprotiline treatment, which could lead to increased synaptic activity or plasticity in the hippocampus and striatum, and may underlie the therapeutic effect of maprotline, and possibly, other antidepressant drugs.
A role for AMPA receptors in mood disorders.
...
1
2
3
4
...